By: Todd Taylor It has long been known that the brain’s ability to metabolize a simple form of sugar called glucose gradually decreases as we age, and there is increasing evidence that this is more pronounced in the brains of patients with Alzheimer’s disease. Now, a new University of Florida…
One challenge to advancing Alzheimer’s disease treatments is that many patients have mixed brain pathologies, meaning more than one disease process is affecting the brain. This can complicate diagnosis, clinical trial design and treatment development because a therapy targeting only one disease process may be less effective if another is…
By: Grace Huff This November, the Norman Fixel Institute for Neurological Diseases at UF Health is bringing awareness to Alzheimer’s disease and supporting the individuals and families affected by it as we recognize Alzheimer’s Awareness Month. In the depths of discovery lies a lab guided by curiosity, courage, and a…
By: Grace Huff The holiday season is often regarded as a time for joy, togetherness, and tradition. For many families, the rituals of decorating, cooking, and celebrating offer a sense of continuity and connection. However, for seniors living with cognitive impairment or Alzheimer’s disease, the holidays can present both emotional…
New research published today suggests there is a link between abnormal blood levels of amyloid — a protein associated with Alzheimer’s disease — and subtle changes in brain microstructures on a type of MRI, findings that could lead to a new way to detect Alzheimer’s earlier in people with no clinical signs.
Attendees will learn about the latest neuroscience research, funding opportunities and can network with researchers across the globe.
UF neuroscientists collaborate on international study revealing a potential therapeutic target for ALS, FTD linked to TDP-43.
University of Florida in Gainesville was featured in this recent news story after they implanted their first patient with DBS for Alzheimer’s Disease. The target was the fornix, which is an important brain region for memory. Contact us about clinical trials at…
This article appeared in the Gainesville Sun about the University of Florida team that is participating in the important trial using deep brain stimulation to treat memory problems in Alzheimer’s disease. UF is part of a small but nationwide study and will be covering the entire South and Southeast U.S.
